Tag: 6

COLUMBUS, Wis., July 24, 2025 (GLOBE NEWSWIRE) -- In a market update released today, Michael Eisenga, CEO of First American Properties LLC, addressed significant trends emerging in the U.S. housing sector for the month of June. Citing a confluence of weakening price trends, rising inventory, and a pullback in single-family home construction, Eisenga emphasized that the second half of 2025 may mark a structural shift in market dynamics—offering buyers more leverage than at any point in the past two years.

DALLAS, July 24, 2025 (GLOBE NEWSWIRE) -- Dorchester Minerals, L.P. (NASDAQ:DMLP) announced today the Partnership’s second quarter 2025 cash distribution. The distribution of $0.620216 per common unit represents activity for the three-month period ended June 30, 2025 and is payable on August 14, 2025 to common unitholders of record as of August 4, 2025.

BOSTON, July 24, 2025 (GLOBE NEWSWIRE) -- The Boston Beer Company, Inc. (NYSE: SAM), today reported financial results for the second quarter ended June 28, 2025. Key results were:

_{⁽¹⁾ Volume is measured on a standard physical case basis and is used to standardize differing package configurations delivered via direct store delivery.}

VERO BEACH, Fla., July 24, 2025 (GLOBE NEWSWIRE) --  (July 24, 2025) – Orchid Island Capital, Inc. (NYSE:ORC) ("Orchid” or the "Company"), a real estate investment trust ("REIT"), today announced results of operations for the three month period ended June 30, 2025.

The In-Studio and Online Event Featured Over 10,000 Bordeaux-centric Bottles From the Collection of Malik M. Hasan, M.D.

[220+ Pages Latest Report] According to a market research study published by Custom Market Insights, the demand analysis of Global CRISPR Gene Editing Market size & share revenue was valued at approximately USD 3.65 Billion in 2024 and is expected to reach USD 4.10 Billion in 2025 and is expected to reach around USD 12.6 Billion by 2034, at a CAGR of 13.01% between 2025 and 2034. The key market players listed in the report with their sales, revenues and strategies are CRISPR Therapeutics AG, Agilent Technologies Inc., Thermo Fisher Scientific Inc., GeneCopoeia Inc., Synthego Corporation, System Biosciences LLC, ToolGen Inc., Rockland Immunochemicals Inc., Horizon Discovery Group PLC, Abcam Inc., Applied StemCell Inc., Cellecta Inc and others.